Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin | Zendy

Cristiana M. NascimentoCarvalho | Zendy; Gabriel XavierSouza | Zendy; AnaLuisa VilasBoas | Zendy; MariaSocorro H. Fontoura | Zendy; Aldina Barral | Zendy; Mirja Puolakkainen | Zendy; Olli Ruuskanen | Zendy

Open Access

Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin

Author(s) -

Cristiana M. NascimentoCarvalho,

Gabriel XavierSouza,

AnaLuisa VilasBoas,

MariaSocorro H. Fontoura,

Aldina Barral,

Mirja Puolakkainen,

Olli Ruuskanen

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx126

Subject(s) - amoxicillin , mycoplasma pneumoniae , medicine , chlamydia , community acquired pneumonia , chlamydia trachomatis , pneumonia , prospective cohort study , chlamydophila pneumoniae , immunology , antibiotics , gastroenterology , chlamydiaceae , microbiology and biotechnology , biology

Atypical bacteria are treatable causative agents of community-acquired pneumonia (CAP). However, there is no conclusive evidence that a child with CAP should receive empirical treatment against such agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research